Strong delivery since 2021: strong 16.2% CAGR organic revenue growth and 32.4% core EBIT margin at constant FX 2021 confirms sustained market outperformance; 9% revenue growth CAGR and EBIT margin at 26% as reported. Well defined playbook for growth: leveraging the powerful combination of leading innovations and advanced digital workflows to make  [ … ]

Third-quarter revenue amounted to CHF 602.2 million, a 8.3% organic revenue growth EMEA remained the key growth driver, NAM showed sequential improvement, APAC solid outside China while patient flow slowdown ahead of VBP 2.0, and LATAM continued its growth path Orthodontics business transformation through a strategic partnership with Smartee and [ … ]

Half-year revenue reached CHF 1.3 billion, growing 10.2% organically, achieving CHF 667.5 million and 9.3% organic revenue growth in the second quarter Core[1] EBIT margin at 26.6% or 27.3% at constant 2024 currency rates in the first half 2025 new product launches are gaining traction – successful iEXCEL launch in Europe Shanghai campus in Ch [ … ]

Strong organic revenue growth of 11.0% in the first quarter and revenue of CHF 680.7 million Varied regional growth dynamics persist, with EMEA and APAC regions outperforming Straumann and SprintRay collaborate to drive unique chairside workflow with 3D printing Global launch of Straumann iEXCEL and EMEA launches of UNIQ and Falcon Outlook 202 [ … ]

Full-year revenue grew organically by 13.7%, reaching CHF 2.5 billion Fourth-quarter revenue showed 11.5% organic growth, amounting to CHF 645 million Core EBIT margin at 26% including currency impact, or 27.6% at constant 2023 currencies, and core net profit at CHF 502 million Implant system iEXCEL launched in key markets, digital platform AXS  [ … ]